' x='0' y='0' width='795' height='447'%3E%3C/rect%3E%3Ctext id='Loading-Preview' font-family='AvenirNext-Bold, Avenir Next' font-size='42' font-weight='bold' fill='%23FFFFFF'%3E%3Ctspan x='228.715' y='211'%3ELoading Preview%3C/tspan%3E%3C/text%3E%3C/g%3E%3C/g%3E%3C/svg%3E)
Description | Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more. |
h1 tags | Gene Therapy. Redefined. |
h2 tags | Therapeutic Program Areas In the News Kriya Appoints Sachiyo Minegishi as Chief Financial Officer Kriya appoints Greg Di Russo, MD as Chief Medical Officer Kriya Announces $320 Million Series D Financing to Advance Pipeline of Gene Therapies for Chronic Diseases of High Unmet Need Our Investors |
Site Speed | 0.94046711921692 |
Alexa Rank: |
0 |
Site's Traffic |
|
| Host | Type | Class | TTL | Target |
| kriyatx.com | HINFO | IN | 3600 |